Montag & Associates’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.73K | Buy |
14
+5
| +56% | +$619 | ﹤0.01% | 860 |
|
|
2025
Q1 | $947 | Buy |
9
+1
| +13% | +$105 | ﹤0.01% | 957 |
|
|
2024
Q4 | $1.05K | Buy |
8
+2
| +33% | +$262 | ﹤0.01% | 947 |
|
|
2024
Q3 | $720 | Hold |
6
| – | – | ﹤0.01% | 1001 |
|
|
2024
Q2 | $860 | Hold |
6
| – | – | ﹤0.01% | 951 |
|
|
2024
Q1 | $824 | Buy |
+6
| New | +$824 | ﹤0.01% | 940 |
|